下一代测序技术在肺部非结核分枝杆菌感染检测中的应用进展

Progress in application of next-generation sequencing technology in detection of pulmonary nontuberculous Mycobacteria infections

  • 摘要: 非结核分枝杆菌(NTM)是除结核分枝杆菌复合群和麻风分枝杆菌外的环境分枝杆菌统称,包含约200个菌种,其中鸟分枝杆菌复合体(MAC)为最常见的致病菌。NTM感染可累及全身多器官系统,其中约90%表现为非结核分枝杆菌肺病(NTM-PD),尤其易发生于已有基础肺部疾病的人群。NTM传统检测方法如抗酸染色和培养法存在灵敏度低、周期长等局限,难以满足临床需求。下一代测序(NGS)的快速发展为NTM诊断带来突破,其高通量、高精度的特性可实现对NTM菌种的快速鉴定和耐药基因分析,显著提升诊断效率。本文系统综述NTM现有检测方法概况、NGS概述以及其在肺部NTM感染检测中的应用,以期为NTM-PD的早期精准诊断和个体化治疗提供新思路。

     

    Abstract: Nontuberculous mycobacteria (NTM) is a collective term for environmental mycobacteria except Mycobacterium tuberculosis complex and Mycobacterium leprae, containing about 200 species, of which Mycobacterium avium complex (MAC) is the most common pathogen. NTM infection can involve multiple organ systems throughout the body, about 90% of which presents with nontuberculous mycobacterial pulmonary disease (NTM-PD), it particularly tends to occur among the population who have already had underlying pulmonary diseases. The traditional detection methods for NTM, such as acid-fast staining and culture, have the limitations such as low sensitivity and long processing time, and fail to meet the clinical needs. The rapid development of next-generation sequencing (NGS) has brought a breakthrough in diagnosis of NTM, the high-throughput and high-precision features enable the rapid identification of NTM species and analysis of drug resistance genes, remarkably improving the diagnostic efficiency. This article provides a systematic review of the current NTM detection methods, an overview of NGS, and its application in detection of pulmonary NTM infections, aiming to offer new ideas for the early, accurate diagnosis and individualized treatment of NTM-PD.

     

/

返回文章
返回